All Sauce from Weekly Sauce:

The societal stress and stigma of being LGBTQ+ can increase a person’s risk of mental health problems, a new study suggests. People in sexual and gender minorities are more likely than heterosexuals to suffer from problems like anxiety, depression, PTSD, bipolar disorder, ADHD, eating disorders and obsessive-compulsive disorder, researchers reported recently in JAMA Network Open.…  read on >  read on >

You aren’t imagining it: The cloud cover isn’t what it used to be, and scientists say it is helping fuel Earth’s hottest temperatures on record. Global temperatures clocked in at roughly 1.5 degrees Celsius above predindustrial averages in both 2023 and 2024.  While climate experts say some of the rise can be explained by a…  read on >  read on >

After three years, $40,000 in medical bills and five insurance denials, April and Justin Beck finally won their battle to get life-changing treatment for their 9-year-old daughter, Emily. Emily, once an energetic kindergartner in Georgia, began experiencing severe behavior issues after battling COVID in 2021. Known for her love of reading and keeping her classmates…  read on >  read on >

Women of color are less likely to receive prompt follow-up testing after abnormal mammogram results, a new study has found. Minority women are less likely than white women to receive a same-day advanced imaging or biopsy after an abnormal mammogram, even though they have similar access to those services, researchers reported. Black women were 44%…  read on >  read on >

People with inflammatory arthritis run a substantially increased risk for mood disorders like depression and anxiety. But these mental health concerns aren’t being adequately addressed by doctors, a new study suggests. Arthritis patients are about as likely to receive either medication or therapy for a mood disorder as people without arthritis, despite their increased risk…  read on >  read on >

Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But a newer lupus drug appears to protect patients from much of this organ damage, a new study suggests. Anifrolumab (brand name Saphnelo) reduced the risk of long-term organ damage progression by about 60%…  read on >  read on >